Skip to main content

Table 2 Univariate predictors of mortality among patients with type 2 diabetes

From: Predictors of mortality among patients with type 2 diabetes in Jordan

Response = Mortality, N = 957
  Confidence interval (95%) P value Odd Ratio
Age, yrs. 1.0389–1.0831 < 0.0001* 1.0630
Male Gender 0.6908–1.6004 0.8147 1.0515
BMI (Kg/m2), n = 171 0.9547–1.0621 0.7221 1.0096
Current smoking 0.4492–1.4399 0.4630 0.8043
Hypertension 4.3030–10.754 0.0007* 7.5423
HF 2.3724–6.5696 < 0.0001* 3.9479
CAD 1.0547–2.4793 0.0264* 1.6171
PAD 0.6947–4.1895 0.2386 1.7060
VTE 1.4064–9.8091 0.0046* 3.7142
Stroke/TIA 1.4797–4.1347 0.0004* 2.4735
AF 2.7713–10.0684 < 0.0001* 5.2823
COPD 1.5455–8.3445 0.0016* 3.5912
CKD 2.8518–7.4478 < 0.0001* 4.6087
Number of CVD comorbidities 1.6666–2.4219 < 0.0001* 2.0005
Diabetic nephropathy 2.2950–9.2144 < 0.0001* 4.5986
Macroalbuminuria 2.9248–7.1905 < 0.0001* 4.5860
Microalbuminuria 1.7395–4.0673 < 0.0001* 2.6599
AKI 5.5478–13.8176 < 0.0001* 8.7554
Dialysis 1.9739–11.3898 0.0001* 4.7415
DKA 0.0901–5.5301 0.7390 0.7095
DM duration 0.9868–1.0496 0.2434 1.0189
DM duration, ≤ > 6 yrs. 1.0940–2.5705 0.0183* 1.6696
Controlled DM 0.4938–2.5243 0.7910 1.1165
LVEF 0.0014–0.1248 0.0001* 0.0129
LA size, cm 2.6298–6.3121 < 0.0001* 4.0400
Cr level 1.2072–1.4613 < 0.0001* 1.3246
LDL 0.9970–1.0038 0.7178 1.0006
HDL 0.9756–1.0053 0.3166 0.9921
Triglyceride 0.9979–1.0002 0.1734 0.9991
Total Cholesterol 0.9971–1.0030 0.8960 1.0001
Fasting plasma glucose 0.9967–1.0011 0.4035 0.9990
HbA1c, % 0.9714–1.1523 0.1865 1.0591
Use of Insulin 1.1038–2.8562 0.0167* 1.7756
Insulin alone 0.3733–4.3551 0.6975 1.2750
Use of OHA 0.3145–3.5348 0.9315 1.0544
OHA alone 0.3623–0.9379 0.0248* 0.5830
Combination of insulin and OHA 1.0627–2.6654 0.0252* 1.6830
ACEi/ARB 0.8771–2.6831 0.1311 1.5340
Beta blockers 1.5761–5.4684 0.0004* 2.9358
Aldosterone antagonists 1.3569–4.4480 0.0023* 2.4567
Thiazide Diuretics 0.9824–2.2912 0.0591 1.5003
Loop Diuretics 2.5343–6.3904 < 0.0001* 4.0639
Statins 0.7100–2.6321 0.3478 1.3671
Digoxin 1.5325–5.2717 0.0006* 2.8424
Ion channel blockers 0.8954–8.7702 0.0649 2.8023
Aspirin 1.0594–4.3620 0.0303* 2.1497
  1. Odd ratio is per unit change in regressor. * is a value <0.05. BMI body mass index, CAD coronary artery disease, PAD peripheral artery disease, TIA transient ischemic attack, AF atrial fibrillation, VTE venous thromboembolism, CKD chronic kidney disease, AKI acute kidney injury, COPD chronic obstructive pulmonary disease; number of cardiovascular morbidities include HT, HF, CAD, PAD and stroke, Hx history, HbA1c glycosylated hemoglobin, DKA diabetic ketoacidosis, ACEI angiotensin converting enzyme inhibitor, ARBs angiotensin-II receptor blockers